Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
Condition:   AsthmaInterventions:   Drug: montelukast sodium;   Drug: placeboSponsor:   Merck Sharp & Dohme Corp.Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2004 Category: Research Source Type: clinical trials

Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
Conditions:   Asthma, Bronchial;   Rhinitis, Allergic, PerennialInterventions:   Drug: MK0476, montelukast sodium;   Drug: Comparator: placeboSponsor:   Merck Sharp & Dohme Corp.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2004 Category: Research Source Type: clinical trials